Therasis

Company financing events and reported valuations.

Latest recorded traffic for Therasis is 0 monthly website visits, down 100% over the last three months. Therasis's team grew 0% over the past year.

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ASAlgae Aura SkincarePremium algae-based skincare products featuring phycocyanin for sustainable and healthy skin solutions	Truth or Consequences, United States	Operational	1	—	—
UMUmimareSustainable aquaculture products from marine organisms.	Figueira da Foz, Portugal	Operational	72,100	$740M	$38.5M
WBWild Coast BiologicsDevelopment of microalgae based biostimulants, biopesticides, biofertilizers and pollination aids	Vancouver, Canada	Operational	72,100	$38.5M	$1.1B
ABAlga BiologicsDeveloping therapeutic antibodies from microalgae using biotechnological processes for application in cancer treatment	Isneauville, France	Operational	18,420	$2.6B	$740M
PHPhycolabsHarnessing seaweed's potential to create eco-friendly textiles, driving a circular and regenerative fashion industry	São Paulo, Brazil	Operational	18,420	$1.1B	$184.2M
MYmyotaPersonalised prebiotic fibre blends for gut health	London, United Kingdom	Operational	18,420	$38.5M	$1.1B
BTByron Bioreactor TechnologiesDesigns and builds low-cost, scalable bioreactor systems for efficient microalgae cultivation across food, pharma, and biotech	Byron Bay, Australia	Operational	4,860	$1.1B	$184.2M
SUSuplemintThemed dietary supplement packs for targeted health needs	Lasne, Belgium	Operational	4,860	$2.6B	$740M

Recent portfolio relationships for companies that also act as investors or acquirers.